Malta-founded artificial intelligence company EBO.ai is expanding into North America through a strategic partnership with MedBridge North America, marking a significant step in its international growth trajectory.

Founder and CEO Gege Gatt described the move as “an important milestone” for the company, as it establishes a new route to market across the United States and Canada. Early deployments and pipeline growth are already being targeted for the second quarter of 2026.

The partnership builds on EBO.ai’s track record across the UK, Europe, and the Middle East, where its AI-driven platform has been deployed in complex, highly regulated environments. The company’s expansion into North America is expected to accelerate adoption of its solutions, particularly within healthcare and financial services.

EBO.ai said the collaboration will enable organisations in both markets to leverage its AI technology to streamline operations and improve customer engagement. “Built on proven success across multiple regions, EBO’s AI is designed to operate in complex, regulated environments and now brings that capability to the US and Canadian markets,” the company noted.

MedBridge North America brings sector-specific expertise to the partnership, specialising in facilitating the entry of international medical product manufacturers into both North American and European markets. Its services span regulatory assistance, sales strategy development, trade show management, and guidance on navigating government support mechanisms.

According to its website, MedBridge’s “proven track record of success, deep industry knowledge, and an extensive network of strategic partners” positions it as a key enabler for companies looking to overcome the regulatory and distribution challenges of the healthcare sector.